PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 2 filers reported holding PDL BIOPHARMA INC in Q1 2009. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2013 | $456,000 | +4.1% | 54,000 | -10.0% | 0.04% | +25.8% |
| Q1 2013 | $438,000 | +3.8% | 60,000 | 0.0% | 0.03% | -8.8% |
| Q4 2012 | $422,000 | -8.7% | 60,000 | 0.0% | 0.03% | -5.6% |
| Q3 2012 | $462,000 | +16.1% | 60,000 | 0.0% | 0.04% | +12.5% |
| Q2 2012 | $398,000 | +4.2% | 60,000 | 0.0% | 0.03% | +6.7% |
| Q1 2012 | $382,000 | +105.4% | 60,000 | +100.0% | 0.03% | +87.5% |
| Q4 2011 | $186,000 | -45.9% | 30,000 | -53.3% | 0.02% | -5.9% |
| Q3 2011 | $344,000 | -6.0% | 64,200 | 0.0% | 0.02% | 0.0% |
| Q2 2011 | $366,000 | +45.8% | 64,200 | +48.6% | 0.02% | -15.0% |
| Q1 2011 | $251,000 | -6.7% | 43,200 | 0.0% | 0.02% | -16.7% |
| Q4 2010 | $269,000 | -0.4% | 43,200 | -0.5% | 0.02% | -7.7% |
| Q1 2010 | $270,000 | -9.4% | 43,400 | 0.0% | 0.03% | -10.3% |
| Q4 2009 | $298,000 | -13.4% | 43,400 | -0.5% | 0.03% | -17.1% |
| Q3 2009 | $344,000 | 0.0% | 43,600 | 0.0% | 0.04% | -14.6% |
| Q2 2009 | $344,000 | +11.3% | 43,600 | 0.0% | 0.04% | -10.9% |
| Q1 2009 | $309,000 | – | 43,600 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |